IntelGenx Technologies

IntelGenx Technologies

Growth Stage

Overview

Raised to Date: Raised: $154,500

Total Commitments ($USD)

Platform

Digital Offering

Start Date

02/15/2024

Close Date

Not Provided

Min. Goal
$750
Max. Goal
$20,000,000
Min. Investment

$750

Security Type

Equity - Preferred

Series

Series A

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$10.00

Pre-Money Valuation

$2,687,310,150

Rolling Commitments ($USD)

Status

Active

Reporting Date

04/15/2024

% of Min. Goal

20,600%

% of Max. Goal

1%

Likelihood of Max
unlikely
Avg. Daily Raise

$2,575

# of Investors

86

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

1999

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Location

Saint Laurent, Quebec

Business Type

Growth

IntelGenx Technologies is raising funds through Reg A+ crowdfunding with Digital Offering as the Broker-Dealer. The company is a leader in the development of oral strips and intends to apply the same thin film technology to prescription medications. IntelGenx Technologies’ oral strip technology increases drug absorption, reduces side effects, and aims to help people struggling with pill swallowing issues. The business has strong industry collaborations and plans to launch its first product, Versafilm, in the second quarter of 2024. Dr. Horst G. Zerbe founded IntelGenx Technologies in 1999. The current crowdfunding campaign has a maximum target of $20 million. The campaign proceeds will be used for product launches, debt repayment, and working capital.

Balance Sheet

Cash and Cash Equivalents

$1,904,000

Investment Securities

$173,000

Accounts and Notes Receivable

$606,000

Property, Plant and Equipment (PP&E)

$3,976,000

Property and Equipment

$3,976,000

Total Assets

$8,113,000

Accounts Payable & Accrued Liabilities

$3,193,000

Long Term Debt

$8,500,000

Total Liabilities

$19,019,000

Total Stockholders' Equity

$-10,906,000

Total Liabilities and Equity

$8,113,000

Statement of Comprehensive Income Information

Total Revenues

$318,000

Costs & Expenses Applicable to Rev

$2,688,000

Depreciation and Amortization

$200,000

Net Income

$-2,759,000

Earnings Per Share - Basic

$-0.01

Earnings Per Share - Diluted

$-0.01

Auditor: Richter LLP
Financials as of: 02/15/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
IntelGenx Technologies on Digital Offering 2024
Platform: Digital Offering
Security Type: Equity - Preferred
Valuation: $2,687,310,150
Price per Share: $10.00

Follow company

Follow IntelGenx Technologies on Digital Offering 2024

Buy IntelGenx Technologies's Deal Report

IntelGenx Technologies Deal Report

Get KingsCrowd’s comprehensive report on IntelGenx Technologies including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether IntelGenx Technologies is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the IntelGenx Technologies deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge